XBIO – xenetic biosciences, inc. (US:NASDAQ)
Stock Stats
News
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting [Yahoo! Finance]
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Xenetic Biosciences, For: Jan 08
Form 4 Xenetic Biosciences, For: Dec 31 Filed by: Kornberg Roger D.
Form 4 Xenetic Biosciences, For: Dec 31 Filed by: Borisenko Grigory G.
Form 4 Xenetic Biosciences, For: Dec 31 Filed by: VINOGRADOV ALEXEY ANDREEVICH
Form 4 Xenetic Biosciences, For: Dec 31 Filed by: Dastoor Firdaus J.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.